WHO praises price cuts for HIV drugs

The World Health Organisation has welcomed the decision of Abbott Laboratories to significantly reduce the price of lopinavir/ritonavir, a second-line antiretroviral therapy to help in the fight against HIV/AIDS.

You need to be an HSJ subscriber to read more

HSJ

Subscribe to read the full article

With an HSJ subscription you’ll get access to:

  • Expert Briefing newsletters, covering nine topics and regions
  • Weekly Catch Up – a summary of the week’s most important stories
  • Unlimited access to hsj.co.uk
  • The HSJ app

Enquire about multi-user access